This series comprised of videos and articles explores the evolving treatment landscape for HER2+ early breast cancer.
EP. 1: Evolving Treatment Strategies in HER2-Positive Early Breast Cancer
Sandra M. Swain, MD, FACP, FASCO, reviews clinical trial data and how they inform the evolving treatment landscape in HER2+ early breast cancer.
EP. 2: Navigating HER2+ Early Breast Cancer: Insights Into the Current Treatment Landscape
In this companion article, Sandra M. Swain, MD, FACP, FASCO, provides insights into effective management of patients with early-stage HER2+ breast cancer and reviews recent data in the evolving treatment landscape.
EP. 3: Managing HER2+ Early Breast Cancer: Insights and Future Horizons
Sandra M. Swain, MD, FACP, FASCO, discusses the potential role for HER2-directed TKIs for the treatment of patients with early-stage HER2+ breast cancer and shares insights about emerging data that could impact the future treatment landscape.
2 Clarke Drive Cranbury, NJ 08512